Clinical Outcomes of Patients with Multiple Myeloma Presenting with Renal Failure
Final response assessment was done at a follow-up of 6 months. Half of the patients achieved a renal complete response; the highest being in the lenalidomide group (83.3%). Patients with eGFR < 15 mL/min/m <sup>2</sup> at presentation fared poorly versus those with eGFR > 15 mL/min/m <sup>2</sup> . Patients who were dialysis-dependent at baseline had poorer renal responses as compared with those who were dialysis-independent. Out of six patients who were initially dialysis-dependent, four (66.6%) became dialysis-independent after treatment.
Authors
- Hemant Malhotra (ORCID: https://orcid.org/0000-0001-5613-5375)
- Prashant Kumbhaj
- Ankur Punia
- Lalit Mohan Sharma (ORCID: https://orcid.org/0000-0002-3262-6708)
- Julia Vasant
- Naveen Gupta (ORCID: https://orcid.org/0000-0002-2695-1985)
- Ajay Yadav (ORCID: https://orcid.org/0000-0001-8507-3767)
- Priyanka Soni
- Suraj Godara
Institutions
- SMS Medical College (IN)
Publication Details
- Journal
- South Asian Journal of Cancer
- Published
- 2025-01-10
- DOI
- https://doi.org/10.1055/s-0044-1801287
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00